Helmholtz Gemeinschaft


Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: Article


Preclinical lead optimization of a 1,2,4-triazole based tankyrase inhibitor.
Waaler, J. and Leenders, R. and Sowa, S.T. and Alam Brinch, S. and Lycke, M. and Nieczypor, P. and Aertssen, S. and Murthy, S. and Galera-Prat, A. and Damen, E. and Wegert, A. and Nazare, M. and Lehtiö, L. and Krauss, S.
Journal of Medicinal Chemistry 63 (13): 6834-6846. 9 July 2020

Development of robust 17(R),18(S)-epoxyeicosatetraenoic acid (17,18-EEQ) analogues as potential clinical antiarrhythmic agents.
Adebesin, A.M. and Wesser, T. and Vijaykumar, J. and Konkel, A. and Paudyal, M. and Lossie, J. and Zhu, C. and Westphal, C. and Puli, N. and Fischer, R. and Schunck, W.H. and Falck, J.
Journal of Medicinal Chemistry 62 (22): 10124-10143. 27 November 2019

Discovery of a novel series of tankyrase inhibitors by a hybridization approach.
Anumala, U.R. and Waaler, J. and Nkizinkiko, Y. and Ignatev, A. and Lazarow, K. and Lindemann, P. and Olsen, P.A. and Murthy, S. and Obaji, E. and Majouga, A.G. and Leonov, S. and von Kries, J.P. and Lehtiö, L. and Krauss, S. and Nazaré, M.
Journal of Medicinal Chemistry 60 (24): 10013-10025. 28 December 2017

Ethyl 2-((4-chlorophenyl)amino)thiazole-4-carboxylate and derivatives are potent inducers of Oct3/4.
Cheng, X. and Yoshida, H. and Raoofi, D. and Saleh, S. and Alborzinia, H. and Wenke, F. and Goehring, A. and Reuter, S. and Mah, N. and Fuchs, H.R. and Andrade-Navarro, M.A. and Adjaye, J. and Gul, S. and Utikal, J. and Mrowka, R. and Woelfl, S.
Journal of Medicinal Chemistry 58 (1): 5742-5750. 13 August 2015

Identification of 2-[4-[(4-methoxyphenyl)methoxy]-phenyl]acetonitrile and derivatives as potent Oct3/4 inducers.
Cheng, X. and Dimou, E. and Alborzinia, H. and Wenke, F. and Goehring, A. and Reuter, S. and Mah, N. and Fuchs, H. and Andrade-Navarro, M.A. and Adjaye, J. and Gul, S. and Harms, C. and Utikal, J. and Klipp, E. and Mrowka, R. and Woelfl, S.
Journal of Medicinal Chemistry 58 (12): 4976-4983. 25 June 2015

Structural characterization of amorfrutins bound to the peroxisome proliferator-activated receptor γ.
de Groot, J.C. and Weidner, C. and Krausze, J. and Kawamoto, K. and Schroeder, F.C. and Sauer, S. and Büssow, K.
Journal of Medicinal Chemistry 56 (4): 1535-1543. 28 February 2013

17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues.
Falck, J.R. and Wallukat, G. and Puli, N. and Goli, M. and Arnold, C. and Konkel, A. and Rothe, M. and Fischer, R. and Mueller, D.N. and Schunck, W.H.
Journal of Medicinal Chemistry 54 (12): 4109-4118. 23 June 2011

Elucidation of a structural basis for the inhibitor-driven, p62 (SQSTM1)-dependent intracellular redistribution of cAMP phosphodiesterase-4A4 (PDE4A4).
Day, J.P. and Lindsay, B. and Riddell, T. and Jiang, Z. and Allcock, R.W. and Abraham, A. and Sookup, S. and Christian, F. and Bogum, J. and Martin, E.K. and Rae, R.L. and Anthony, D. and Rosair, G.M. and Houslay, D.M. and Huston, E. and Baillie, G.S. and Klussmann, E. and Houslay, M.D. and Adams, D.R.
Journal of Medicinal Chemistry 54 (9): 3331-3347. 12 May 2011

Synthesis and biological evaluation of spin-labeled alkylphospholipid analogs.
Mravljak, J. and Zeisig, R. and Pecar, S.
Journal of Medicinal Chemistry 48 (20): 6393-6399. 6 October 2005

Quinols as novel therapeutic agents. 2.(1) 4-(1-arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry, J.M. and Bradshaw, T.D. and Fichtner, I. and Ren, R. and Schwalbe, C.H. and Wells, G. and Chew, E.H. and Stevens, M.F. and Westwell, A.D.
Journal of Medicinal Chemistry 48 : 639-644. 27 January 2005

PDBLIG: classification of small molecular protein binding in the Protein Data Bank.
Chalk, A.J. and Worth, C.L. and Overington, J.P. and Chan, A.W.E.
Journal of Medicinal Chemistry 47 (15): 3807-3816. 15 July 2004

Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound.
Kratz, F. and Warnecke, A. and Scheuermann, K. and Stockmar, C. and Schwab, J. and Lazar, P. and Drueckes, P. and Esser, N. and Drevs, J. and Rognan, D. and Bissantz, C. and Hinderling, C. and Folkers, G. and Fichtner, I. and Unger, C.
Journal of Medicinal Chemistry 45 (25): 5523-5533. 5 December 2002

Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'- deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta and epsilon nor HIV-1 reverse transcriptase.
von Janta-Lipinski, M. and Costisella, B. and Ochs, H. and Huebscher, U. and Hafkemeyer, P. and Matthes, E.
Journal of Medicinal Chemistry 41 : 2040-2046. 1 January 1998

Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.
Shi, D.F. and Bradshaw, T.D. and Wrigley, S. and McCall, C.J. and Lelieveld, P. and Fichtner, I. and Stevens, M.F.G.
Journal of Medicinal Chemistry 39 : 3375-3384. 1 January 1996

This list was generated on Sat Sep 19 02:28:15 2020 CEST.
Open Access
MDC Library